Tg(ACTB-Wld*)5Cole
Transgene Detail
|
Symbol: |
Tg(ACTB-Wld*)5Cole |
Name: |
transgene insertion 5, Michael Coleman |
MGI ID: |
MGI:5911079 |
Synonyms: |
deltaNLSR213A,R215A WldS, deltaNLS WldS |
Transgene: |
Tg(ACTB-Wld*)5Cole Location: unknown
|
Alliance: |
Tg(ACTB-Wld*)5Cole page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Tg(ACTB-Wld*)5Cole expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Note |
mouse |
Wld (MGI:98952) |
expresses Wlds fusion gene with mutations that disable the NLS |
|
|
|
Mutation details: A construct consisting of the human beta actin promoter followed by a mutant cDNA for Wlds that contains engineered C>G point mutations changing arginine codons 213 and 215 to alanine (p.Arg213Ala, p.Arg215Ala), was injected into the pronuclei of fertilized (C57BL/6 x CBA)F1 eggs that do not express Wlds. The two mutations weaken or disable the nuclear localization signal, thus changing the localization of the translated peptide towards the cytoplasm. A small percentage of peptides is still directed to the nucleus.
(J:144846)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:144846 Beirowski B, et al., Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci. 2009 Jan 21;29(3):653-68 |
All: |
1 reference(s) |
|